Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
30.6M
-
Number of holders
-
4
-
Total 13F shares, excl. options
-
1.49K
-
Shares change
-
-1.05K
-
Total reported value, excl. options
-
$10.7K
-
Value change
-
-$9.38K
-
Number of buys
-
1
-
Number of sells
-
-4
-
Price
-
$7.09
Significant Holders of Quoin Pharmaceuticals, Ltd. - Ordinary Shares (QNRX) as of Q3 2025
6 filings reported holding QNRX - Quoin Pharmaceuticals, Ltd. - Ordinary Shares as of Q3 2025.
Quoin Pharmaceuticals, Ltd. - Ordinary Shares (QNRX) has 4 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.49K shares
of 30.6M outstanding shares and own 0% of the company stock.
Largest 6 shareholders include RHUMBLINE ADVISERS (1.21K shares), GAMMA Investing LLC (278 shares), SBI Securities Co., Ltd. (2 shares), UBS Group AG (1 shares), RAYMOND JAMES FINANCIAL INC (0 shares), and MORGAN STANLEY (0 shares).
This table shows the top 4 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.